Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Phase III Study of Surufatinib in Treating Advanced Pancreatic Neuroendocrine Tumors

NCT02589821

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

the 307 Hospital of People's Liberation Army Beijing, Beijing Municipality, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

177Lutetium-DOTA-Octreotate Therapy in Somatostatin Receptor-Expressing Neuroendocrine Neoplasms

NCT01237457

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States

View Trial Details

Completed

Optimising Molecular Radionuclide Therapy

NCT04922801

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +12 more
Locations: Guy's and St Thomas Hospitals Foundation Trust London, United Kingdom

View Trial Details

Completed

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

NCT01253161

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +12 more
Locations: Stanford Cancer Institute Stanford, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)

NCT03273712

Conditions: Central Nervous System Neoplasms, Glioma, Medulloblastoma, +17 more
Locations: University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

View Trial Details

Completed

Nutrition in Gastrointestinal Tumors

NCT04476082

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +42 more
Locations: University Medicine Greifswald Greifswald, Germany

View Trial Details

Completed

Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

NCT03673943

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States

View Trial Details

Completed

TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors

NCT03079440

Conditions: Adenocarcinoma, Capecitabine, Carcinoma, +10 more
Locations: Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

A Real-world Comparison of FNB and FNA in IHC-required Lesions.

NCT05565066

Conditions: Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +20 more
Locations: Tongji Hospital, Tongji Medical College, HUST Wuhan, Hubei, China

View Trial Details

Completed

Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases

NCT03590119

Conditions: Liver Metastases, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Antoni van Leeuwenhoek Cancer Institute Amsterdam, Netherlands

Erasmus MC Rotterdam, Netherlands

University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions